Exchange Bulletin
Willow Biosciences Inc. (WLLW) To Trade On Toronto Stock Exchange
December 3, 2019
| Issuer: | Willow Biosciences Inc. (the "Company") |
| Security: | Common shares |
| Symbol(s): | WLLW |
| Number of securities issued and outstanding: | 78,891,879 |
| Number of securities reserved for issuance: | 33,069,223 |
| Listing category: | Industrial, Non-Exempt Issuer |
| Trading currency: | CDN$ |
| Listing date: | December 4, 2019 (as at 5:01 pm) |
| Posted for trading date: | December 5, 2019 (at the opening) |
| Other market(s): | The common shares have been listed on the Canadian Securities Exchange ("CSE") since April 15, 2019 under the symbol "WLLW". TSX is advised that the common shares will be delisted from the CSE on December 4, 2019 (at the close). |
| Temporary market maker: | W.D. Latimer Co. Ltd. |
| Security ownership registration: | Non-certificated inventory |
| Investor relations: | Troy Talkkari Vice President, Corporate Development 403-618-1117 t.talkkari@willowbio.com |
| Incorporation: | Business Corporations Act (Alberta) |
| Fiscal year end: | December 31 |
| Nature of business: | The Company is a biotechnology company focusing on developing yeast as a production platform for high-grade pharmaceutical ingredients typically sourced from plants. Currently, the Company is focused on genetically engineering yeast strains to produce economically viable titers of cannabinoids. |
| Transfer agent and registrar: | Alliance Trust Company at its principal office in Calgary. |
| Dividends: | None anticipated in the foreseeable future. |
| Sponsorship: | Eight Capital |
| TSX contact: | Chris Birkett, Director, Toronto Stock Exchange. |
